On October 16, 2014, the fee-for-service (FFS) pharmacy program implemented clinical criteria for Hepatitis C Virus (HCV) drug therapy, as was recommended by the Drug Utilization Review Board (DURB) at the September 18, 2014 meeting. Included in this criteria were the following ...
This interactive workshop, led by renowned hepatologist Dr. Robert Gish, is designed to provide health care providers and their medical team with core medical knowledge of hepatitis B (HBV) and hepatitis C (HCV).
- NY Governor Announces Nation’s First State-Level Hep C Elimination Strategy March 16, 2018
- NYC Council Viral Hepatitis Initiative March 9, 2018
- Sign On | Urge Congress to Appropriate Opioid Funding for Hep C/ HIV February 14, 2018
- Training Manual for Treatment Activists | Hep C & HIV Coinfection February 2, 2018
May 1 - May 31
May 24 @ 8:00 am - 4:00 pm EDT
May 24 @ 4:30 pm - 5:30 pm EDT